🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHeadaches on GLP-1 — looking for input Page 2

Headaches on GLP-1 — looking for input

robert_kc Wed, Feb 21, 2024 at 11:15 PM 19 replies 2,294 viewsPage 2 of 4
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Feb 22, 2024 at 1:27 AM#6
KevinCompounds said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

Last edited: Feb 22, 2024 at 7:27 AM
39 9julia.endo, JessicaM_2024, TomFromTexas and 36 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Feb 22, 2024 at 2:18 AM#7

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Last edited: Feb 22, 2024 at 3:18 AM
38 8traveltech_sara, AttorneyGrant, DebRD_ATL and 35 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Feb 22, 2024 at 3:09 AM#8
Dr.KarenChen said:
I dislike how confidently this board tells people to push through.

Adding the part of the answer the thread has not reached. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

37 7maya_sedona, stefan_berlin, Dr.EM_Chicago and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Feb 22, 2024 at 4:00 AM#9

One thing that is still open after PharmD_Rodriguez’s answer:

What distinguishes the nausea you can titrate through from the nausea that means stop?

36 6NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 33 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Feb 22, 2024 at 8:07 AM#10

Reporting back.

Update. It was not the dose, it was that I had stopped drinking anything because drinking made me feel full. Fixing that fixed most of it.

14 12PharmHunterJen, TomTeleRx, DoseLogDan and 11 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register